{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:42Z","timestamp":1707524502833},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,7]]},"DOI":"10.7759\/cureus.22935","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T22:50:34Z","timestamp":1646693434000},"source":"Crossref","is-referenced-by-count":0,"title":["Radiological Findings on Chest Computed Tomography in Patients With the Primary Diagnosed Chronic Lymphoproliferative Diseases"],"prefix":"10.7759","author":[{"given":"Ganna","family":"Usenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kateryna","family":"Gashynova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0309-2","article-title":"A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells","volume":"10","author":"Gasparini VR","year":"2020","unstructured":"Gasparini VR, Binatti A, Coppe A, et al.. A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells. Blood Cancer J. 2020, 10:1-11. 10.1038\/s41408-020-0309-2","journal-title":"Blood Cancer J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal A","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010, 60:277-300. 10.3322\/caac.20073","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.2128","article-title":"Global burden of multiple myeloma: a systematic analysis for the Global Burden of Disease Study 2016","volume":"4","author":"Cowan AJ","year":"2018","unstructured":"Cowan AJ, Allen C, Barac A, et al.. Global burden of multiple myeloma: a systematic analysis for the Global Burden of Disease Study 2016. JAMA Oncol. 2018, 4:1221-7. 10.1001\/jamaoncol.2018.2128","journal-title":"JAMA Oncol"},{"key":"ref4","unstructured":"Howlader N, Noone AM, Krapcho M, et al.. SEER Cancer Statistics Review, 1975-2017, National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2017\/, based on November 2019 SEER data submission, posted to the SEER web site, April. (2020). Accessed: February 5, 2021: https:\/\/seer.cancer.gov\/archive\/csr\/1975_2017\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/952698","article-title":"Therapy-related late adverse events in Hodgkin\u2019s Lymphoma","volume":"2013","author":"Gotti M","year":"2013","unstructured":"Gotti M, Fiaccadori V, Bono E, et al.. Therapy-related late adverse events in Hodgkin\u2019s Lymphoma. Lymphoma. 2013, 2013:1-7. 10.1155\/2013\/952698","journal-title":"Lymphoma"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)00036-3","article-title":"Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial","volume":"3","author":"Ferreri AJ","year":"2016","unstructured":"Ferreri AJ, Cwynarski K, Pulczynski E, et al.. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol. 2016, 3:217-27. 10.1016\/S2352-3026(16)00036-3","journal-title":"Lancet Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1179\/1973947815Y.0000000025","article-title":"Severe and fatal adverse events risk associated with rituximab addition to B-cell non-Hodgkin's lymphoma (B-NHL) chemotherapy: a meta-analysis","volume":"27","author":"Hua Q","year":"2015","unstructured":"Hua Q, Zhu Y, Liu H. Severe and fatal adverse events risk associated with rituximab addition to B-cell non-Hodgkin's lymphoma (B-NHL) chemotherapy: a meta-analysis. J Chemother. 2015, 27:365-70. 10.1179\/1973947815Y.0000000025","journal-title":"J Chemother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000517531","article-title":"Outcome of a real-world patient cohort with secondary CNS lymphoma treated with high-intensity chemoimmunotherapy and autologous stem cell transplantation","volume":"44","author":"Thiele B","year":"2021","unstructured":"Thiele B, Binder M, Schliffke S, et al.. Outcome of a real-world patient cohort with secondary CNS lymphoma treated with high-intensity chemoimmunotherapy and autologous stem cell transplantation. Oncol Res Treat. 2021, 44:375-80. 10.1159\/000517531","journal-title":"Oncol Res Treat"},{"key":"ref9","article-title":"Effectiveness and safety of methotrexate monotherapy in patients with pulmonary sarcoidosis","volume":"283","author":"Gavrysyuk V","year":"2018","unstructured":"Gavrysyuk V, Merenkova E, Gumeniuk G, Gumeniuk M, Dziublyk Y. Effectiveness and safety of methotrexate monotherapy in patients with pulmonary sarcoidosis. Georgian Medical News. 2018, 283:34-8.","journal-title":"Georgian Medical News"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14785","article-title":"Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study","volume":"178","author":"Strati P","year":"2017","unstructured":"Strati P, Parikh SA, Chaffee KG, et al.. Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study. Br J Haematol. 2017, 178:394-402. 10.1111\/bjh.14785","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2020.1913","article-title":"Rate of respiratory symptoms in na\u00efve patients with chronic lymphocytic leukemia","volume":"56","author":"Gashynova K","year":"2020","unstructured":"Gashynova K, Usenko G. Rate of respiratory symptoms in na\u00efve patients with chronic lymphocytic leukemia. Eur Respir J. 2020, 56:1913. 10.1183\/13993003.congress-2020.1913","journal-title":"Eur Respir J"},{"key":"ref12","unstructured":"Unified clinical protocol of the primary, secondary (specialized), tertiary (highly specialized) medical care of non-Hodgkin lymphomas and Hodgkin's lymphoma. Ministry of Health of Ukraine. (2013). Accessed. February 5, 2021:  https:\/\/dec.gov.ua\/wp-content\/uploads\/2019\/11\/2013_866_ykpmd_limfomy.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.31655\/2307-3373-2019-2-46-55","article-title":"Possibilities of computed tomography in examination of patients with bronchial asthma, chronic obstructive pulmonary disease and in the study of bone mineral density. (Article in Ukranian)","volume":"2","author":"Gumeniuk MI","year":"2019","unstructured":"Gumeniuk MI, Gumeniuk GL, Linnik NI, Ignatieva V\u0406. Possibilities of computed tomography in examination of patients with bronchial asthma, chronic obstructive pulmonary disease and in the study of bone mineral density. (Article in Ukranian). Asthma Allergy. 2019, 2:46-55. 10.31655\/2307-3373-2019-2-46-55","journal-title":"Asthma Allergy"},{"key":"ref14","article-title":"Possibilities of multi-slice spiral computed tomography using for patient with chronic obstructive pulmonary disease and asthma examination. (Article in Ukranian)","volume":"3-4","author":"Lynnik MI","year":"2009","unstructured":"Lynnik MI, Gumenyuk GL, Musienko NM. Possibilities of multi-slice spiral computed tomography using for patient with chronic obstructive pulmonary disease and asthma examination. (Article in Ukranian). Asthma Allergy. 2009, 3-4:55-61.","journal-title":"Asthma Allergy"},{"key":"ref15","article-title":"Mathematical Processing and Analysis of Biomedical Data. 2nd Edition","author":"Antomonov MY","year":"2018","unstructured":"Antomonov MY. Mathematical Processing and Analysis of Biomedical Data. 2nd Edition. Pharmacy market of Ukraine following the results of I quarter. 2019: Helicopter View. 2017 (ed): Medinform, Kyiv; 2018."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/78202-radiological-findings-on-chest-computed-tomography-in-patients-with-the-primary-diagnosed-chronic-lymphoproliferative-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:29Z","timestamp":1707507689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/78202-radiological-findings-on-chest-computed-tomography-in-patients-with-the-primary-diagnosed-chronic-lymphoproliferative-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.22935","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,7]]}}}